001     289461
005     20241117013749.0
024 7 _ |a 10.1186/s12883-024-03620-4
|2 doi
024 7 _ |a pmid:38614986
|2 pmid
024 7 _ |a altmetric:163920572
|2 altmetric
037 _ _ |a DKFZ-2024-00783
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Holz, Anja
|b 0
245 _ _ |a Childhood and adolescence factors and multiple sclerosis: results from the German National Cohort (NAKO).
260 _ _ |a Heidelberg
|c 2024
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1713269043_20786
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Multiple Sclerosis (MS) represents the most common inflammatory neurological disease causing disability in early adulthood. Childhood and adolescence factors might be of relevance in the development of MS. We aimed to investigate the association between various factors (e.g., prematurity, breastfeeding, daycare attendance, weight history) and MS risk.Data from the baseline assessment of the German National Cohort (NAKO) were used to calculate adjusted hazard ratios (HR) and 95% confidence intervals (CI) for the association between childhood and adolescence factors and risk of MS. Analyses stratified by sex were conducted.Among a total of 204,273 participants, 858 reported an MS diagnosis. Male sex was associated with a decreased MS risk (HR 0.48; 95% CI 0.41-0.56), while overweight (HR 2.03; 95% CI 1.41-2.94) and obesity (HR 1.89; 95% CI 1.02-3.48) at 18 years of age compared to normal weight were associated with increased MS risk. Having been breastfed for ≤ 4 months was associated with a decreased MS risk in men (HR 0.59; 95% CI 0.40-0.86) compared to no breastfeeding. No association with MS risk was observed for the remaining factors.Apart from overweight and obesity at the age of 18 years, we did not observe considerable associations with MS risk. The proportion of cases that can be explained by childhood and adolescence factors examined in this study was low. Further investigations of the association between the onset of overweight and obesity in childhood and adolescence and its interaction with physical activity and MS risk seem worthwhile.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Adolescence
|2 Other
650 _ 7 |a Childhood
|2 Other
650 _ 7 |a Epidemiology
|2 Other
650 _ 7 |a Multiple Sclerosis
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Adolescent
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Overweight: epidemiology
|2 MeSH
650 _ 2 |a Multiple Sclerosis: epidemiology
|2 MeSH
650 _ 2 |a Pediatric Obesity
|2 MeSH
650 _ 2 |a Exercise
|2 MeSH
700 1 _ |a Obi, Nadia
|b 1
700 1 _ |a Ahrens, Wolfgang
|b 2
700 1 _ |a Berger, Klaus
|b 3
700 1 _ |a Bohn, Barbara
|b 4
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 5
|u dkfz
700 1 _ |a Fischer, Beate
|b 6
700 1 _ |a Fricke, Julia
|b 7
700 1 _ |a Führer, Amand
|b 8
700 1 _ |a Gastell, Sylvia
|b 9
700 1 _ |a Greiser, Karin Halina
|0 P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b
|b 10
|u dkfz
700 1 _ |a Harth, Volker
|b 11
700 1 _ |a Heise, Jana-Kristin
|b 12
700 1 _ |a Holleczek, Bernd
|b 13
700 1 _ |a Keil, Thomas
|b 14
700 1 _ |a Klett-Tammen, Carolina J
|b 15
700 1 _ |a Leitzmann, Michael
|b 16
700 1 _ |a Lieb, Wolfgang
|b 17
700 1 _ |a Meinke-Franze, Claudia
|b 18
700 1 _ |a Michels, Karin B
|b 19
700 1 _ |a Mikolajczyk, Rafael
|b 20
700 1 _ |a Nimptsch, Katharina
|b 21
700 1 _ |a Peters, Annette
|b 22
700 1 _ |a Pischon, Tobias
|b 23
700 1 _ |a Riedel, Oliver
|b 24
700 1 _ |a Schikowski, Tamara
|b 25
700 1 _ |a Schipf, Sabine
|b 26
700 1 _ |a Schmidt, Börge
|b 27
700 1 _ |a Schulze, Matthias B
|b 28
700 1 _ |a Stang, Andreas
|b 29
700 1 _ |a Hellwig, Kerstin
|b 30
700 1 _ |a Riemann-Lorenz, Karin
|b 31
700 1 _ |a Heesen, Christoph
|b 32
700 1 _ |a Becher, Heiko
|b 33
773 _ _ |a 10.1186/s12883-024-03620-4
|g Vol. 24, no. 1, p. 123
|0 PERI:(DE-600)2041347-6
|n 1
|p 123
|t BMC neurology
|v 24
|y 2024
|x 1471-2377
856 4 _ |u https://inrepo02.dkfz.de/record/289461/files/s12883-024-03620-4.pdf
856 4 _ |u https://inrepo02.dkfz.de/record/289461/files/s12883-024-03620-4.pdf?subformat=pdfa
|x pdfa
909 C O |o oai:inrepo02.dkfz.de:289461
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2024
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BMC NEUROL : 2022
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-05-02T09:05:38Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-05-02T09:05:38Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Open peer review
|d 2023-05-02T09:05:38Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-24
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-24
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-08-24
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-08-24
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2023-08-24
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2023-08-24
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Präventive Onkologie
|x 1
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21